D-dimer testing is useful to exclude deep vein thrombosis in elderly outpatients

J Thromb Haemost. 2008 Jul;6(7):1072-6. doi: 10.1111/j.1538-7836.2008.03007.x. Epub 2008 Jul 1.

Abstract

Background: Deep vein thrombosis (DVT) can be safely and reliably excluded in patients with a low clinical probability and a negative D-dimer result but the accuracy and utility of such a strategy is unclear in elderly patients.

Objectives: We sought to compare the performance of the Wells pretest probability (PTP) model and D-dimer testing between patients of different age groups and to examine the utility of the two PTP model classification schemes (low/moderate/high vs. unlikely/likely) in excluding DVT in elderly outpatients.

Patients/methods: Pooled analysis of databases from three prospective diagnostic studies evaluating consecutive outpatients with suspected DVT.

Results: A total of 2696 patients were evaluated. DVT was diagnosed in 400 (15%) patients overall and in 50 out of 325 (15.5%) patients > or = 60 years old. The PTP distribution and the prevalence of DVT in each PTP category were similar among the different age groups. The negative predictive values of a low or unlikely PTP score in combination with a negative D-dimer result were 99% for all groups. A negative D-dimer in combination with a low or unlikely PTP excluded 21.7% and 31% of patients > or = 80 years old, respectively.

Conclusions: The combination of a low or unlikely PTP with a negative D-dimer result can effectively and safely exclude DVT in a significant proportion of elderly outpatients. However, this clinical prediction rule needs to be prospectively validated with different D-dimer assays in this specific population.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Algorithms
  • Diagnosis, Differential
  • Diagnostic Techniques, Cardiovascular
  • Fibrin Fibrinogen Degradation Products / analysis*
  • Humans
  • Predictive Value of Tests*
  • Probability
  • Prospective Studies
  • Venous Thromboembolism / diagnosis*

Substances

  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D